N2-iBu-3',5'-TIPDS-15N1-Gr
| Catalog No. | R2-033 |
| Molecular Formula | C26H45N5O7Si2 |
| Molecular Weight | 596.83 |
N2-iBu-3',5'-TIPDS-15N1-Gr
N2-iBu-3',5'-TIPDS-15N1-Gr - N (Normal) is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Related Products
Specifications
Specifications
-
Catalog No.R2-033
-
SMILESO[C@@H]1[C@H](O[Si](C(C)C)(C(C)C)O[Si](C(C)C)(C(C)C)OC2)[C@@H]2O[C@H]1N(C=N3)C4=C3C([15NH]C(NC(C(C)C)=O)=N4)=O
-
Molecular FormulaC26H45N5O7Si2
-
Molecular Weight596.83
Documentation
Documentation
-
Catalog No.R2-033
-
SMILESO[C@@H]1[C@H](O[Si](C(C)C)(C(C)C)O[Si](C(C)C)(C(C)C)OC2)[C@@H]2O[C@H]1N(C=N3)C4=C3C([15NH]C(NC(C(C)C)=O)=N4)=O
-
Molecular FormulaC26H45N5O7Si2
-
Molecular Weight596.83
Why choose Hongene?
Trusted Partner in Nucleic Acid
Integrated Supply & Commercial Scale
With 26+ years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates 1.67 million sq. ft Oligonucleotide Manufacturing Facility, with advanced equipments including multiple OligoPilot™ and OligoProcess™ synthesizers (10-1800 mmol). 48 flexible production lines enable one-stop seamless scaling-up of API production from gram-level to tons and acheive high purity of 98%, meeting NMPA, FDA, and EMA standards.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.
